These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 17511879)

  • 1. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors.
    Winter SL; Bosnoyan-Collins L; Pinnaduwage D; Andrulis IL
    BMC Cancer; 2007 May; 7():85. PubMed ID: 17511879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.
    Saunus JM; French JD; Edwards SL; Beveridge DJ; Hatchell EC; Wagner SA; Stein SR; Davidson A; Simpson KJ; Francis GD; Leedman PJ; Brown MA
    Cancer Res; 2008 Nov; 68(22):9469-78. PubMed ID: 19010922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haplo-insufficiency of BRCA1 in sporadic breast cancer.
    Staff S; Isola J; Tanner M
    Cancer Res; 2003 Aug; 63(16):4978-83. PubMed ID: 12941823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.
    Pinilla SM; Honrado E; Hardisson D; Benítez J; Palacios J
    Breast Cancer Res Treat; 2006 Sep; 99(1):85-90. PubMed ID: 16541313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic characterization of protein phosphatase 1 complexes in ischemia-reperfusion and ischemic tolerance.
    Cid C; Garcia-Bonilla L; Camafeita E; Burda J; Salinas M; Alcazar A
    Proteomics; 2007 Sep; 7(17):3207-18. PubMed ID: 17683050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers.
    Palacios J; Honrado E; Osorio A; Cazorla A; Sarrió D; Barroso A; Rodríguez S; Cigudosa JC; Diez O; Alonso C; Lerma E; Dopazo J; Rivas C; Benítez J
    Breast Cancer Res Treat; 2005 Mar; 90(1):5-14. PubMed ID: 15770521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCoR-L1 variation and breast cancer.
    Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
    Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial breast cancers without mutations in BRCA1 or BRCA2 have low cyclin E and high cyclin D1 in contrast to cancers in BRCA mutation carriers.
    Aaltonen K; Blomqvist C; Amini RM; Eerola H; Aittomäki K; Heikkilä P; Nevanlinna H
    Clin Cancer Res; 2008 Apr; 14(7):1976-83. PubMed ID: 18381935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of SRp40 affecting CD44 splicing is associated with the clinical outcome of lymph node metastasis in human breast cancer.
    Huang CS; Shen CY; Wang HW; Wu PE; Cheng CW
    Clin Chim Acta; 2007 Sep; 384(1-2):69-74. PubMed ID: 17651715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
    Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
    Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.
    Melchor L; Honrado E; García MJ; Alvarez S; Palacios J; Osorio A; Nathanson KL; Benítez J
    Oncogene; 2008 May; 27(22):3165-75. PubMed ID: 18071313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards a comprehensive analysis of the protein phosphatase 1 interactome in Drosophila.
    Bennett D; Lyulcheva E; Alphey L; Hawcroft G
    J Mol Biol; 2006 Nov; 364(2):196-212. PubMed ID: 17007873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis.
    Flores-Delgado G; Liu CW; Sposto R; Berndt N
    J Proteome Res; 2007 Mar; 6(3):1165-75. PubMed ID: 17274640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of BRCA1 expression in sporadic breast carcinomas.
    Lambie H; Miremadi A; Pinder SE; Bell JA; Wencyk P; Paish EC; Macmillan RD; Ellis IO
    J Pathol; 2003 Jun; 200(2):207-13. PubMed ID: 12754741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High incidence of protein-truncating TP53 mutations in BRCA1-related breast cancer.
    Holstege H; Joosse SA; van Oostrom CT; Nederlof PM; de Vries A; Jonkers J
    Cancer Res; 2009 Apr; 69(8):3625-33. PubMed ID: 19336573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1 gene in breast cancer.
    Rosen EM; Fan S; Pestell RG; Goldberg ID
    J Cell Physiol; 2003 Jul; 196(1):19-41. PubMed ID: 12767038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Potapova A; Hoffman AM; Godwin AK; Al-Saleem T; Cairns P
    Cancer Res; 2008 Feb; 68(4):998-1002. PubMed ID: 18281473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.